1887

Abstract

The aim of this study was to explore the relationship between hepatitis B virus (HBV) core antigen (HBc) mutations and the post-operative prognosis of HBV-related hepatocellular carcinoma (HCC). In total, 98 patients suffering from HBV-related HCC and treated with surgery were enrolled, with a 48 month follow-up. The preCore/Core region of the HBV genome from tumour tissue (TT) and paired adjacent non-tumour tissue (ANTT) of these patients was sequenced, and a phylogenetic tree was reconstructed. The correlations between the viral features and evolutionary divergence of preCore/Core amino acid sequences from 67 paired TTs and ANTTs were analysed. Cox proportional hazard model analysis was applied for post-operative hazard risk evaluation. Phylogenetic analysis revealed that all of the sequences were ascribed to genotype C. The evolutionary divergence of amino acid sequences from matched TTs and ANTTs was significantly negatively correlated with serum and intrahepatic HBV DNA levels. Multivariate analysis showed that the HBc E77 mutation was associated with shorter overall survival, and HBc S87 and P156 mutations were independent risk factors for relapse. Furthermore, in contrast to with patients without the S87 mutation, no correlation was observed between serum HBV DNA and intrahepatic HBV DNA in HCC patients with the S87 mutation. Analysis of the intrahepatic sequence may advance our understanding of viral status; thus, it is useful for prognosis prediction for HBV-related HCC.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000790
2017-06-22
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/6/1399.html?itemId=/content/journal/jgv/10.1099/jgv.0.000790&mimeType=html&fmt=ahah

References

  1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–132 [CrossRef][PubMed]
    [Google Scholar]
  2. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;15:5–13 [CrossRef][PubMed]
    [Google Scholar]
  3. WHO Globoscan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 Geneva: World Health Organization; 2012
    [Google Scholar]
  4. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84–S101 [CrossRef][PubMed]
    [Google Scholar]
  5. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317–320 [CrossRef][PubMed]
    [Google Scholar]
  6. Ma NF, Lau SH, Hu L, Xie D, Wu J et al. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 2008;14:5061–5068 [CrossRef][PubMed]
    [Google Scholar]
  7. Liu H, Shi W, Luan F, Xu S, Yang F et al. Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase. Virus Genes 2010;40:174–182 [CrossRef][PubMed]
    [Google Scholar]
  8. Sung WK, Zheng H, Li S, Chen R, Liu X et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012;44:765–769 [CrossRef][PubMed]
    [Google Scholar]
  9. Saitta C, Tripodi G, Barbera A, Bertuccio A, Smedile A et al. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int 2015;35:2311–2317 [CrossRef][PubMed]
    [Google Scholar]
  10. Liang HW, Wang N, Wang Y, Wang F, Fu Z et al. Hepatitis B virus–human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 2016;64:278–291 [CrossRef][PubMed]
    [Google Scholar]
  11. Lau CC, Sun T, Ching AK, He M, Li JW et al. Viral–human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 2014;25:335–349 [CrossRef][PubMed]
    [Google Scholar]
  12. Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K et al. Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 2003;23:5282–5292 [CrossRef][PubMed]
    [Google Scholar]
  13. Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 2011;305:123–143 [CrossRef][PubMed]
    [Google Scholar]
  14. Wei X, Xiang T, Ren G, Tan C, Liu R et al. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013;25:439–446 [CrossRef][PubMed]
    [Google Scholar]
  15. Martin-Lluesma S, Schaeffer C, Robert EI, van Breugel PC, Leupin O et al. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008;48:1467–1476 [CrossRef][PubMed]
    [Google Scholar]
  16. Gai X, Zhao P, Pan Y, Shan H, Yue X et al. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Int J Biochem Cell Biol 2013;45:1174–1185 [CrossRef][PubMed]
    [Google Scholar]
  17. Jia B, Guo M, Li G, Yu D, Zhang X et al. Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. J Virol 2015;89:2041–2051 [CrossRef][PubMed]
    [Google Scholar]
  18. Liu W, Lin YT, Yan XL, Ding YL, Wu YL et al. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J 2015;29:1113–1123 [CrossRef][PubMed]
    [Google Scholar]
  19. Cai Y, He S, Luo N, Luo L, Gong Q. [Effect of hepatitis B virus X protein on the cell cycle of primary mouse hepatocytes]. Zhonghua Gan Zang Bing Za Zhi 2012;20:211–215 (in Chinese)[PubMed]
    [Google Scholar]
  20. Dimattia MA, Watts NR, Stahl SJ, Grimes JM, Steven AC et al. Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein. Structure 2013;21:133–142 [CrossRef]
    [Google Scholar]
  21. Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology 1989;170:595–597 [CrossRef][PubMed]
    [Google Scholar]
  22. Bouckaert R, Alvarado-Mora MV, Pinho JR. Evolutionary rates and HBV: issues of rate estimation with Bayesian molecular methods. Antivir Ther 2013;18:497–503 [CrossRef][PubMed]
    [Google Scholar]
  23. Chotiyaputta W, Lok AS. Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 2009;6:453–462 [CrossRef][PubMed]
    [Google Scholar]
  24. Huang Y, Tong S, Tai AW, Hussain M, Lok AS. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Gastroenterology 2011;141:1412–1421 [CrossRef][PubMed]
    [Google Scholar]
  25. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84–S101 [CrossRef][PubMed]
    [Google Scholar]
  26. Kim DW, Lee SA, Hwang ES, Kook YH, Kim BJ. Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma. PLoS One 2012;7:e47372 [CrossRef][PubMed]
    [Google Scholar]
  27. Lin CL, Liu CH, Chen W, Huang WL, Chen PJ et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:1098–1103 [CrossRef][PubMed]
    [Google Scholar]
  28. Mathews P, Lee D, Chung YH, Kim JA, Lee JH et al. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma. Ann Surg Oncol 2013;20:1216–1222 [CrossRef][PubMed]
    [Google Scholar]
  29. Datta S, Ghosh A, Dasgupta D, Ghosh A, Roychoudhury S et al. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma. PLoS One 2014;9:e110012 [CrossRef][PubMed]
    [Google Scholar]
  30. Yeh CT, So M, Ng J, Yang HW, Chang ML et al. Hepatitis B virus–DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 2010;52:1922–1933 [CrossRef][PubMed]
    [Google Scholar]
  31. Su CW, Chiou YW, Tsai YH, Teng RD, Chau GY et al. The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy. PLoS One 2013;8:e66457 [CrossRef][PubMed]
    [Google Scholar]
  32. Xie Y, Liu S, Zhao Y, Zhang L, Zhao Y et al. Precore/core region mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma. PLoS One 2015;10:e0133393 [CrossRef][PubMed]
    [Google Scholar]
  33. Xie Y, Liu S, Zhao Y, Guo Z, Xu J. X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma. Tumor Biol 2014;35:10325–10331 [CrossRef][PubMed]
    [Google Scholar]
  34. Kang HY, Lee S, Park SG, Yu J, Kim Y et al. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J 2006;398:311–317 [CrossRef][PubMed]
    [Google Scholar]
  35. Vanlandschoot P, Cao T, Leroux-Roels G. The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 2003;60:67–74 [CrossRef][PubMed]
    [Google Scholar]
  36. Ceres P, Stray SJ, Zlotnick A. Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L. J Virol 2004;78:9538–9543 [CrossRef][PubMed]
    [Google Scholar]
  37. Le Pogam S, Yuan TT, Sahu GK, Chatterjee S, Shih C. Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol 2000;74:9099–9105 [CrossRef][PubMed]
    [Google Scholar]
  38. Kefalakes H, Budeus B, Walker A, Jochum C, Hilgard G et al. Adaptation of the hepatitis B virus core protein to CD8+ T-cell selection pressure. Hepatology 2015;62:47–56 [CrossRef][PubMed]
    [Google Scholar]
  39. Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol 1993;41:221–229 [CrossRef][PubMed]
    [Google Scholar]
  40. Zhang Y, Ren Y, Wu Y, Zhao B, Qiu L et al. The L60V variation in hepatitis B virus core protein elicits new epitope-specific cytotoxic T lymphocytes and enhances viral replication. J Virol 2013;87:8075–8084 [CrossRef][PubMed]
    [Google Scholar]
  41. Abbott WG, Tsai P, Leung E, Trevarton A, Ofanoa M et al. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J Virol 2010;84:621–629 [CrossRef][PubMed]
    [Google Scholar]
  42. Cui X, Luckenbaugh L, Bruss V, Hu J. Alteration of mature nucleocapsid and enhancement of covalently closed circular DNA formation by hepatitis B virus core mutants defective in complete-virion formation. J Virol 2015;89:10064–10072 [CrossRef][PubMed]
    [Google Scholar]
  43. Liu W, Lin YT, Yan XL, Ding YL, Wu YL et al. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J 2015;29:1113–1123 [CrossRef][PubMed]
    [Google Scholar]
  44. Jia B, Guo M, Li G, Yu D, Zhang X et al. Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7. J Virol 2015;89:2041–2051 [CrossRef][PubMed]
    [Google Scholar]
  45. Gai X, Zhao P, Pan Y, Shan H, Yue X et al. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner. Int J Biochem Cell Biol 2013;45:1174–1185 [CrossRef][PubMed]
    [Google Scholar]
  46. Lee H, Kim H, Lee SA, Won YS, Kim HI et al. Upregulation of endoplasmic reticulum stress and reactive oxygen species by naturally occurring mutations in hepatitis B virus core antigen. J Gen Virol 2015;96:1850–1854 [CrossRef][PubMed]
    [Google Scholar]
  47. Zhong J, Gao YQ, Sun XH, Zhu XJ, Li M. High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in eastern China. Acta Pharmacol Sin 2012;33:1271–1276 [CrossRef][PubMed]
    [Google Scholar]
  48. Yin J, Zhang H, Li C, Gao C, He Y et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 2008;29:1685–1691 [CrossRef][PubMed]
    [Google Scholar]
  49. Shi W, Carr MJ, Dunford L, Zhu C, Hall WW et al. Identification of novel inter-genotypic recombinants of human hepatitis B viruses by large-scale phylogenetic analysis. Virology 2012;427:51–59 [CrossRef][PubMed]
    [Google Scholar]
  50. Zhu Y, Jin Y, Cai X, Bai X, Chen M et al. Hepatitis B virus core protein variations differ in tumor and adjacent nontumor tissues from patients with hepatocellular carcinoma. Intervirology 2012;55:29–35 [CrossRef][PubMed]
    [Google Scholar]
  51. Hosono S, Tai PC, Wang W, Ambrose M, Hwang DG et al. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 1995;212:151–162 [CrossRef][PubMed]
    [Google Scholar]
  52. Han Y, Gong L, Sheng J, Liu F, Li XH et al. Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing. Clin Microbiol Infect 2015;21:797.e1–798.e1 [CrossRef][PubMed]
    [Google Scholar]
  53. Bonhoeffer S, Sniegowski P. Virus evolution: the importance of being erroneous. Nature 2002;420:367–369 [CrossRef][PubMed]
    [Google Scholar]
  54. Luvisa BK, Hassanein TI. Hepatitis B virus infection and liver decompensation. Clin Liver Dis 2016;20:681–692 [CrossRef][PubMed]
    [Google Scholar]
  55. Zhu Y, Jin Y, Guo X, Bai X, Chen T et al. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2010;19:2623–2630 [CrossRef][PubMed]
    [Google Scholar]
  56. Ni YH, Chang MH, Hsu HY, Tsuei DJ. Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma. Gut 2003;52:122–125[PubMed][CrossRef]
    [Google Scholar]
  57. Xu H, Zhao M, Lou G, Zheng M, Cao Q et al. New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing. PLoS One 2015;10:e123139 [CrossRef][PubMed]
    [Google Scholar]
  58. Köck J, Nassal M, Deres K, Blum HE, von Weizsäcker F. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA. J Virol 2004;78:13812–13818 [CrossRef][PubMed]
    [Google Scholar]
  59. Liu Z, Luo K, He H, Hou J. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?. J Viral Hepat 2005;12:146–153 [CrossRef][PubMed]
    [Google Scholar]
  60. Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol 2014;61:408–417 [CrossRef][PubMed]
    [Google Scholar]
  61. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725–2729 [CrossRef][PubMed]
    [Google Scholar]
  62. Wang H, Fang M, Gu X, Ji Q, Li D et al. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China. PLoS One 2014;9:e107162 [CrossRef][PubMed]
    [Google Scholar]
  63. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406–425[PubMed]
    [Google Scholar]
  64. Bryson v, Vogel H. J. (editors) Evolving Genes and Proteins New York: Academic Press; 1965; pp.97–166[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000790
Loading
/content/journal/jgv/10.1099/jgv.0.000790
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error